Trials / Not Yet Recruiting
Not Yet RecruitingNCT06539221
Sphingolipids in Asthma Pathogenesis
Sphingomyelin in Asthma Pathogenesis
- Status
- Not Yet Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- Peking University Third Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The study aims to investigate the relationship between the small molecule metabolite sphingolipids and asthma clinical features and explore its involvement in asthma pathogenesis.
Conditions
Timeline
- Start date
- 2024-09-01
- Primary completion
- 2025-09-01
- Completion
- 2026-09-01
- First posted
- 2024-08-06
- Last updated
- 2024-08-06
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06539221. Inclusion in this directory is not an endorsement.